<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190903044677N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2019-11-09</date_registration>
      <primary_sponsor>Iran University of Medical Sciences</primary_sponsor>
      <public_title>Treatment of the Distal Radius Fracture with Closed Reduction and Percutaneous Pinning without ‎Superficial Radial Nerve Exploration</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the Treatment of the Distal Radius Fracture with Closed Reduction and Percutaneous Pinning with and without ‎Superficial Radial Nerve Exploration</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2019-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/41893</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization will be done using a computer-generated random number list. For this purpose, the ‎patients will be numbered from 1 to 100. Within this range, 50 random numbers will be generated by ‎Excel software. These random numbers will be matched with the patients' numbers, and ‎corresponding patients will be allocated into the case group. The remaining 50 patients will be ‎allocated to the control group. Accordingly, participants will randomly be assigned in a 1:1 ‎ratio into the two study groups, Blinding description: The patients will be blinded from the group assignment.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Distal radius fracture.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Treatment of distal radius fracture with closed reduction and percutaneous pinning without ‎superficial radial nerve exploration. Intervention 2: Control group: Treatment of distal radius fracture with closed reduction and percutaneous pinning with ‎superficial radial nerve exploration.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the data associated with this study are sharable upon request, after anonymizing the participants.

When:
6 months after the publication of the results

To whom:
Academic investigators

Conditions:
The applicant should provide sufficient documents to prove his/her academic identity. Allowed use of the data is dependent on the confirmation of the performers of this study.

Where to obtain:
Dr. Pouria Tabrizian, Shafa Orthopedic Hospital, Mojahedine-eslam Ave., Tehran.
Tel: 00982133542041
Email: tabrizian.pouria@gmail.com

How to obtain:
Email application for the data request, Evaluation of the request, identification of the applicant, the reason for requesting data, evaluation of the provided reasons, sending data through email in case of confirming the provided reasons.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Pouria Tabrizian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mojaheine-eslam Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1157637131</zip>
        <telephone>+98 21 3354 2041</telephone>
        <email>tabrizian.p@iums.ac.ir</email>
        <affiliation>Shafa Orthopedic Hospital</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Pouria Tabrizian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mojahedine-eslam Ave.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1157637131</zip>
        <telephone>+98 21 3354 2041</telephone>
        <email>tabrizian.p@iums.ac.ir</email>
        <affiliation>Shafa Orthopedic Hospital</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age of more than 18 years
Providing written consent to participate in the study</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>A history of distal radius fracture
Concomitant injury affecting the outcome of treatment</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M84.333A</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stress fracture, right radius, initial encounter for fracture</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Treatment of distal radius fracture with closed reduction and percutaneous pinning without ‎superficial radial nerve exploration</i_keyword>
      <i_keyword>Control group: Treatment of distal radius fracture with closed reduction and percutaneous pinning with ‎superficial radial nerve exploration</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>First dorsal web sensation. Timepoint: Before the intervention and two days after the end of intervention. Method of measurement: Patients' clinical examination.</prim_outcome>
      <prim_outcome>Paresthesia‎. Timepoint: Before the intervention and two days after the end of intervention. Method of measurement: Patients' clinical examination.</prim_outcome>
      <prim_outcome>Hyperesthesia‎. Timepoint: Before the intervention and two days after the end of intervention. Method of measurement: Patients' clinical examination.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Wrist range of motion. Timepoint: Before the intervention and 12 months after the end of intervention. Method of measurement: Goniometer.</sec_outcome>
      <sec_outcome>Wrist function. Timepoint: Before the intervention and 12 months after the end of intervention. Method of measurement: DASH questionaire.</sec_outcome>
      <sec_outcome>Pinch strength. Timepoint: Before the intervention and 12 months after the end of intervention. Method of measurement: Dinamometer.</sec_outcome>
      <sec_outcome>Pain. Timepoint: Before the intervention and 12 months after the end of intervention. Method of measurement: Visual analogue scale.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Iran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-07-01</approval_date>
        <contact_name>Ethics committee of Iran University of Medical Sciences</contact_name>
        <contact_address>Next to the Milad tower, Shahid Hemmat Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
